These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30334469)

  • 21. [The application of scales and characteristics of disability in the common genotypes of Charcot-Marie-Tooth disease].
    Liu X; Zhang RX; Liu L; Xie YZ; Lin ZQ; Zhao Q; Cao WQ; Zhu XY; Li XB
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):131-136. PubMed ID: 33455129
    [No Abstract]   [Full Text] [Related]  

  • 22. Tibialis posterior tendon transfer corrects the foot drop component of cavovarus foot deformity in Charcot-Marie-Tooth disease.
    Dreher T; Wolf SI; Heitzmann D; Fremd C; Klotz MC; Wenz W
    J Bone Joint Surg Am; 2014 Mar; 96(6):456-62. PubMed ID: 24647501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stance and swing phase ankle phenotypes in youth with Charcot-Marie-Tooth type 1: An evaluation using comprehensive gait analysis techniques.
    Õunpuu S; Pierz K; Garibay E; Acsadi G; Wren TAL
    Gait Posture; 2022 Oct; 98():216-225. PubMed ID: 36179412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients.
    Don R; Serrao M; Vinci P; Ranavolo A; Cacchio A; Ioppolo F; Paoloni M; Procaccianti R; Frascarelli F; De Santis F; Pierelli F; Frascarelli M; Santilli V
    Clin Biomech (Bristol, Avon); 2007 Oct; 22(8):905-16. PubMed ID: 17686557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of physical activity comparing people with Charcot-Marie-Tooth disease to normal control subjects.
    Ramdharry GM; Pollard AJ; Grant R; Dewar EL; Laurá M; Moore SA; Hallsworth K; Ploetz T; Trenell MI; Reilly MM
    Disabil Rehabil; 2017 Aug; 39(17):1753-1758. PubMed ID: 27684376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
    Pagliano E; Moroni I; Baranello G; Magro A; Marchi A; Bulgheroni S; Ferrarin M; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):237-242. PubMed ID: 22003938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraepidermal nerve fibre density as biomarker in Charcot-Marie-Tooth disease type 1A.
    Hartmannsberger B; Doppler K; Stauber J; Schlotter-Weigel B; Young P; Sereda MW; Sommer C
    Brain Commun; 2020; 2(1):fcaa012. PubMed ID: 32954280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.
    Kennedy RA; Carroll K; McGinley JL; Paterson KL
    J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding medication safety and Charcot-Marie-Tooth disease: a patient perspective.
    Socha Hernandez AV; Deeks LS; Shield AJ
    Int J Clin Pharm; 2020 Dec; 42(6):1507-1514. PubMed ID: 32804316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot study.
    Maggi G; Monti Bragadin M; Padua L; Fiorina E; Bellone E; Grandis M; Reni L; Bennicelli A; Grosso M; Saporiti R; Scorsone D; Zuccarino R; Crimi E; Schenone A
    Am J Phys Med Rehabil; 2011 Aug; 90(8):628-37. PubMed ID: 21681064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.
    Morrow JM; Sinclair CD; Fischmann A; Machado PM; Reilly MM; Yousry TA; Thornton JS; Hanna MG
    Lancet Neurol; 2016 Jan; 15(1):65-77. PubMed ID: 26549782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do different foot types affect the 6-min walk test capacity of younths with Charcot-Marie-Tooth neuropathy ?
    Rogean de Jesus Alves de Baptista C; Garcia B; Cardoso J; Nascimento Elias A; Parra Buzzetti B; Claudia Mattiello-Sverzut A
    BMC Pediatr; 2022 May; 22(1):277. PubMed ID: 35562696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vibration perception among children and adolescents with Charcot-Marie-tooth disease and implications for foot posture.
    Cardoso J; Rogean de Jesus Alves de Baptista C; Parra Buzzetti B; Dallemole Sartor C; Marques Júnior W; de Camargo Neves Sacco I; Mattiello-Sverzut AC
    Clin Biomech (Bristol, Avon); 2023 Dec; 110():106114. PubMed ID: 37804594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An anterior ankle-foot orthosis improves walking economy in Charcot-Marie-Tooth type 1A patients.
    Menotti F; Laudani L; Damiani A; Mignogna T; Macaluso A
    Prosthet Orthot Int; 2014 Oct; 38(5):387-92. PubMed ID: 24100074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responsiveness of gait analysis parameters in a cohort of 71 CMT subjects.
    Lencioni T; Piscosquito G; Rabuffetti M; Bovi G; Di Sipio E; Diverio M; Moroni I; Padua L; Pagliano E; Schenone A; Pareyson D; Ferrarin M
    Neuromuscul Disord; 2017 Nov; 27(11):1029-1037. PubMed ID: 28844614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electromyographic and biomechanical analysis of step negotiation in Charcot Marie Tooth subjects whose level walk is not impaired.
    Lencioni T; Piscosquito G; Rabuffetti M; Sipio ED; Diverio M; Moroni I; Padua L; Pagliano E; Schenone A; Pareyson D; Ferrarin M
    Gait Posture; 2018 May; 62():497-504. PubMed ID: 29679921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of Charcot-Marie-Tooth Neuropathy Score in children with type 1A disease.
    Haberlová J; Seeman P
    Pediatr Neurol; 2010 Dec; 43(6):407-10. PubMed ID: 21093731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gait and footwear in children and adolescents with Charcot-Marie-Tooth disease: A cross-sectional, case-controlled study.
    Kennedy RA; McGinley JL; Paterson KL; Ryan MM; Carroll K
    Gait Posture; 2018 May; 62():262-267. PubMed ID: 29579702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Afferent control of walking: are there distinct deficits associated to loss of fibres of different diameter?
    Nardone A; Corna S; Turcato AM; Schieppati M
    Clin Neurophysiol; 2014 Feb; 125(2):327-35. PubMed ID: 23948160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.